Skip to main content
. 2022 Feb 7;14(2):e21987. doi: 10.7759/cureus.21987

Table 1. Study cohort descriptive statistics.

COPD: chronic obstructive pulmonary disease, TIA: transient ischemic attack, GCS: Glasgow Coma Scale, BP: blood pressure, MAP: mean arterial pressure, SpO2: peripheral oxygen saturation, ABG: arterial blood gas, Δ (A-a): O2 alveolar-arterial oxygen gradient

Variable All patients (n = 101)   Variable All patients (n = 101)
Age, years, mean ± SD 73.2 ± 15.9   Fatigue 11 (10.9)
Gender, n (%)     Myalgias or arthralgias 10 (9.9)
  Male 54 (53.5)   Diarrhea 7 (6.9)
  Female 47 (46.5)   Dysosmia/Dysgeusia 2 (2)
Comorbidities, n (%)     GCS < 15 21 (20.8)
  Hypertension 59 (58.4)   Vital signs, mean ± SD  
  Diabetes mellitus 13 (11.9)   Systolic BP, mmHg 121.5 ± 19.3
  Smoking 8 (7.9)   Diastolic BP, mmHg 71.1 ± 11.6
  COPD 25 (24.8)   MAP, mmHg 87.9 ± 12.6
  Asthma 3 (3)   Heart rate, beats/min 88 ± 17.7
Other respiratory diseases 8 (7.9)   Respiratory rate, breaths/min 23.6 ± 7
  Ischemic heart disease (IHD) 15 (14.9)   SpO2, % 92.5 ± 4.8
  Oncologic condition 8 (7.9)   Body temperature, °C 37.5 ± 0.9
  Chronic kidney disease (CKD) 11 (10.9)   ABG analysis, mean ± SD  
  History of stroke or TIA 12 (11.9)   pH 7.5 ± 0.1
  Immunodeficiency 2 (2)   PaCO2, mmHg 32 ± 6
Clinical features, n (%)     PaO2, mmHg 56.9 ± 10.2
  Fever 93 (92.1)   HCO3-, mmol/L 23.6 ± 3.3
  Shortness of breath (SOB) 63 (62.4)   Lactate, mmol/L 1.3 ± 0.6
  Cough 51 (50.5)   P/F ratio 267.6 ± 50
  Sore throat 3 (3)   Δ (A-a) O2 53.5 ± 11.9
  Headache 2 (2)   ROX index 20.3 ± 7.1